BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21528811)

  • 1. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
    Alves C; Lima R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent primary hyperphosphatemic tumoral calcinosis: a case report.
    Rangaswamy M; Jayashree K; Saggam P; Vimala MG
    Acta Cytol; 2010; 54(5 Suppl):1003-6. PubMed ID: 21053587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete resolution of tumoral calcinosis after renal transplantation.
    Miyamoto M; Shibagaki Y; Kimura K
    Urology; 2012 Jun; 79(6):e90-1. PubMed ID: 22516362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
    Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
    Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphatemic tumoral calcinosis.
    Mallick S; Ahmad Z; Gupta AK; Mathur SR
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperphosphatemic tumoral calcinosis: a case report.
    Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
    Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.
    Goldenstein PT; Neves PD; Balbo BE; Elias RM; Pereira AC; Onuchic LF; Jüppner H; Jorgetti V; Abensur H; Moysés RM
    Am J Kidney Dis; 2018 Sep; 72(3):457-461. PubMed ID: 29548779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.
    Yamaguchi T; Sugimoto T; Imai Y; Fukase M; Fujita T; Chihara K
    Bone; 1995 Apr; 16(4 Suppl):247S-250S. PubMed ID: 7626311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumoral calcinosis, diaphysitis, and hyperphosphatemia.
    Clarke E; Swischuk LE; Hayden CK
    Radiology; 1984 Jun; 151(3):643-6. PubMed ID: 6718723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.
    Zuo QY; Cao X; Liu BY; Yan D; Xin Z; Niu XH; Li C; Deng W; Dong ZY; Yang JK
    J Endocrinol Invest; 2020 Feb; 43(2):173-183. PubMed ID: 31535357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumoral calcinosis: report of a case and brief review of the literature.
    Abraham Z; Rozner I; Rozenbaum M
    J Dermatol; 1996 Aug; 23(8):545-50. PubMed ID: 8854587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
    Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
    Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfamilial hyperphosphatemic tumoral calcinosis with ulnar neuropathy.
    Shetty GM; Murari AS; Shah SV; Dhengle S
    Joint Bone Spine; 2009 Mar; 76(2):198-201. PubMed ID: 19073370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral calcinosis in two infants.
    Rodriguez-Peralto JL; Lopez-Barea F; Torres A; Rodriguez-Gonzalez JI; Diaz-Faes J
    Clin Orthop Relat Res; 1989 May; (242):272-6. PubMed ID: 2706857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies.
    Roberts MS; Burbelo PD; Egli-Spichtig D; Perwad F; Romero CJ; Ichikawa S; Farrow E; Econs MJ; Guthrie LC; Collins MT; Gafni RI
    J Clin Invest; 2018 Dec; 128(12):5368-5373. PubMed ID: 30226830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis.
    Ichikawa S; Gray AK; Padgett LR; Reilly AM; Unsicker TR
    J Bone Miner Res; 2014 Sep; 29(9):2017-23. PubMed ID: 24692172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial tumoral calcinosis in three patients in the same family].
    Yurdoğlu C; Ozbaydar MU; Adaş M; Ozger H
    Acta Orthop Traumatol Turc; 2007; 41(3):244-8. PubMed ID: 17876123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial tumoral calcinosis: a forty-year follow-up on one family.
    Carmichael KD; Bynum JA; Evans EB
    J Bone Joint Surg Am; 2009 Mar; 91(3):664-71. PubMed ID: 19255228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral calcinosis: serial images to monitor successful dietary therapy.
    Manaster BJ; Anderson TM
    Skeletal Radiol; 1982; 8(2):123-5. PubMed ID: 7100939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.